Effects of Raloxifene on Fracture Severity in Postmenopausal Women with Osteoporosis: Results from the MORE Study
β Scribed by E. Siris; J. D. Adachi; Y. Lu; T. Fuerst; G. G. Crans; M. Wong; K. D. Harper; H. K. Genant
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 104 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective Although oral bisphosphonates are effective treatments for postmenopausal women with osteoporosis, oral dosing may be unsuitable for some patients. An efficacious intravenously administered bisphosphonate could be beneficial for such patients. Ibandronate, a potent nitroge
## Abstract Denosumab reduces the risk of new vertebral and nonvertebral fractures. Previous trials suggest that the efficacy of antiresorptives on fractures might differ by patients' characteristics, such as age, bone mineral density (BMD), and fracture history. In the FREEDOM study, 7808 women ag